As many as 10% of early-onset metastatic colorectal cancer (mCRC) cases may be attributable to undiagnosed inflammatory bowel disease (IBD), according to a study presented at the 2022 AACR Special...
Read more© Pharma News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.